Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Showing 20 of 0 results

Not applicableStudy completedNCT06368453
What this trial is testing

Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test

Who this might be right for
Human Immunodeficiency Virus I InfectionHuman Immunodeficiency Virus II Infection
bioLytical Laboratories 1,728
Testing effectiveness (Phase 2)Study completedNCT01549119
What this trial is testing

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

Who this might be right for
HIV-1 Infection
InnaVirVax 33
Testing effectiveness (Phase 2)Study completedNCT03525730
What this trial is testing

LRAs United as a Novel Anti-HIV Strategy.

Who this might be right for
HIV-1-infection
Erasmus Medical Center 28
Post-approval studies (Phase 4)Study completedNCT04296695
What this trial is testing

Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection

Who this might be right for
HIV-1-infection
Peking Union Medical College Hospital 202
Large-scale testing (Phase 3)Study completedNCT01386294
What this trial is testing

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Who this might be right for
HIV Prevention
CONRAD 2,059
Post-approval studies (Phase 4)Study completedNCT03683524
What this trial is testing

EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS

Who this might be right for
HIV-1 Infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 96
Testing effectiveness (Phase 2)WithdrawnNCT03074786
What this trial is testing

Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)

Who this might be right for
HIV-1-infection
International Partnership for Microbicides, Inc.
Large-scale testing (Phase 3)Study completedNCT00002441
What this trial is testing

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

Who this might be right for
HIV InfectionsHIV Seronegativity
VaxGen 5,000
Testing effectiveness (Phase 2)Study completedNCT02099994
What this trial is testing

Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults

Who this might be right for
AIDS
University of Oxford 72
Post-approval studies (Phase 4)Ended earlyNCT00981773
What this trial is testing

The St. Marys and The Mater Switch Study

Who this might be right for
HIV Infections
Imperial College London 18
Testing effectiveness (Phase 2)Study completedNCT00056641
What this trial is testing

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 328
Testing effectiveness (Phase 2)Ended earlyNCT00865566
What this trial is testing

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Early research (Phase 1)Study completedNCT00002353
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Large-scale testing (Phase 3)Study completedNCT00421551
What this trial is testing

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 225
Post-approval studies (Phase 4)UnknownNCT00011895
What this trial is testing

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
GlaxoSmithKline 400
Large-scale testing (Phase 3)Study completedNCT02121795
What this trial is testing

Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF

Who this might be right for
HIV-1 Infection
Gilead Sciences 668
Not applicableStudy completedNCT00618371
What this trial is testing

Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia

Who this might be right for
HIV Infection
University of Pittsburgh 10
Not applicableEnrolling By InvitationNCT02699736
What this trial is testing

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Who this might be right for
HIVHepatitis BHepatitis C+10 more
Rigshospitalet, Denmark 23,000
Testing effectiveness (Phase 2)Study completedNCT02716675
What this trial is testing

Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,699
Large-scale testing (Phase 3)UnknownNCT04022967
What this trial is testing

ANRS 12372 MODERATO Study

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 480
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation